SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-21-007538
Filing Date
2021-03-31
Accepted
2021-03-31 17:25:38
Documents
87
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1020596
2 ex10-18.htm EX-10.18 332360
3 ex21-1.htm EX-21.1 7178
4 ex23-1.htm EX-23.1 4057
5 ex23-2.htm EX-23.2 4259
6 ex31-1.htm EX-31.1 17634
7 ex31-2.htm EX-31.2 17277
8 ex32-1.htm EX-32.1 7666
9 ex32-2.htm EX-32.2 7389
  Complete submission text file 0001493152-21-007538.txt   5656376

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE FILE prph-20201231.xml EX-101.INS 829581
11 XBRL SCHEMA FILE prph-20201231.xsd EX-101.SCH 61803
12 XBRL CALCULATION FILE prph-20201231_cal.xml EX-101.CAL 91375
13 XBRL DEFINITION FILE prph-20201231_def.xml EX-101.DEF 237193
14 XBRL LABEL FILE prph-20201231_lab.xml EX-101.LAB 463150
15 XBRL PRESENTATION FILE prph-20201231_pre.xml EX-101.PRE 361776
Mailing Address 711 STEWART AVENUE GARDEN CITY NEW YORK NY 11530
Business Address 711 STEWART AVENUE GARDEN CITY NEW YORK NY 11530 (215) 345-0919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21617 | Film No.: 21794757
SIC: 2834 Pharmaceutical Preparations